Legacy Bridge, LLC Bristol Myers Squibb CO Transaction History

Legacy Bridge, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	SELL	$57.89 - $64.73 $144,725 - $161,825	-2,500 Reduced 11.08%	20,058 $1.16 Million
Q4 2022 Jan 11, 2023	BUY	$68.48 - $81.09 $20,201 - $23,921	295 Added 1.33%	22,558 $0
Q3 2021 Oct 26, 2021	SELL	$59.17 - $69.31 $72,483 - $84,904	-1,225 Reduced 5.22%	22,263 $1.32 Million
Q2 2021 Aug 03, 2021	SELL	$61.91 - $67.42 $65,005 - $70,791	-1,050 Reduced 4.28%	23,488 $1.57 Million
Q1 2021 Apr 29, 2021	BUY	$59.34 - $66.74 $130,963 - $147,295	2,207 Added 9.88%	24,538 $1.55 Million
Q4 2020 Feb 02, 2021	BUY	$57.74 - $65.43 $92,384 - $104,688	1,600 Added 7.72%	22,331 $1.39 Million
Q3 2020 Oct 19, 2020	BUY	$57.43 - $63.64 $1.03 Million - $1.14 Million	17,918 Added 636.97%	20,731 $1.25 Million
Q2 2020 Aug 04, 2020	BUY	$54.82 - $64.09 $6,194 - $7,242	113 Added 4.19%	2,813 $165,000
Q1 2020 Apr 09, 2020	SELL	$46.4 - $67.43 $1,763 - $2,562	-38 Reduced 1.39%	2,700 $150,000
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $119,973 - $156,495	2,438 Added 812.67%	2,738 $176,000
Q4 2018 Jan 25, 2019	BUY	$48.76 - $63.23 $14,628 - $18,969	300 New	300 $16,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Legacy Bridge, LLC, based on Form 13F filings with the SEC.

Stay updated on Legacy Bridge, LLC with notifications on news.